Tafenoquine Succinate
CAS No. 106635-81-8
Tafenoquine Succinate ( WR 238605 (Succinate) )
Catalog No. M26474 CAS No. 106635-81-8
Tafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 140 | Get Quote |
|
10MG | 215 | Get Quote |
|
25MG | 338 | Get Quote |
|
50MG | 439 | Get Quote |
|
100MG | 644 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTafenoquine Succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.
-
DescriptionTafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.(In Vivo):When tested at two times its ED100 (6 mg/kg), Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice .
-
SynonymsWR 238605 (Succinate)
-
PathwayOthers
-
TargetOther Targets
-
Recptormicrotubule
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106635-81-8
-
Formula Weight581.6
-
Molecular FormulaC28H34F3N3O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCC(O)=O.COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Choi BH, Chattopadhaya S, Thanh le N, Feng L, Nguyen QT, Lim CB, Harikishore A, Nanga RP, Bharatham N, Zhao Y, Liu X, Yoon HS. Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization. PLoS One. 2014 Oct 29;9(10):e110955.
molnova catalog
related products
-
DDD107498 succinate
DDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).
-
Emodepside
A semisynthetic derivative of PF1022A, and novel cyclo-depsipeptide anthelmintic which is efficacious against a variety of gastrointestinal nematodes.
-
ELQ-300
ELQ-300 is bioavailable antimalarial agent acts as an inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1).